Roche will invest $750 million to double the size of its Genentech unit’s manufacturing facility in Hillsboro, Oregon. The new outlay will support the construction of a fill-finish plant that will produce drug-delivery devices, such as prefilled syringes and auto-injectors. The funding will also bring 250 new, high-wage jobs online, Roche said.
Roche earmarks $750M to double the size of its Oregon manufacturing facility
Latest from Blog
Scientists deploy Merck’s Ebola vaccine in DRC
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Google Glass came out when I was in college, and they were dismissed as
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
For most localized solid tumors, it’s common for surgeons to try to preserve as much of the diseased organ as possible, removing only the cancer along with some healthy tissue surrounding it
Global Mild Cognitive Impairment Nutrition Market — Analysis of Key Trends, Regional Growth, Top Players, and a 10-year Forecast from 2026 to 2036.
Mild Cognitive Impairment Nutrition Market worth USD 420.1 million in 2026 is growing at a CAGR of 10.6% to reach USD 1,150.4 million by 2036. Danone Nutricia (Souvenaid), Nestle Health Science, Aker
STAT+: How a Trump loyalist got the FDA nomination
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. RFK
